ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer

Oncotarget

Volumn 4, Issue 11, 2013, Pages 2096-2107

  Holzmann, Christian ^a   Kilch, Tatiana ^a   Kappel, Sven ^a   Armbrüster, Andrea ^a   Jung, Volker ^a   Stöckle, Michael ^a   Bogeski, Ivan ^a   Schwarz, Eva C ^a   Peinelt, Christine ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

CRAC channel; Membrane androgen receptor; Orai channel; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN ORAI3; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL CULTURE; DOWN REGULATION; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN SECRETION; SEQUENCE HOMOLOGY;

CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CELL LINE; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84890219581     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1483     Document Type: Article

References (69)

1. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988; 4854: 889-895
2. Huang P, Chandra V and Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu. Rev. Physiol. 2010; 247-272
3. Cleve A, Fritzemeier KH, Haendler B, Heinrich N, Moller C, Schwede W and Wintermantel T. Pharmacology and clinical use of sex steroid hormone receptor modulators. Handb. Exp. Pharmacol. 2012; 214: 543-587
4. Michels G and Hoppe UC. Rapid actions of androgens. Front. Neuroendocrinol. 2008; 2: 182-198
5. Wagner TF, Loch S, Lambert S, Straub I, Mannebach S, Mathar I, Dufer M, Lis A, Flockerzi V, Philipp SE and Oberwinkler J. Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells. Nat. Cell Biol. 2008; 12: 1421-1430
6. Dambaki C, Kogia C, Kampa M, Darivianaki K, Nomikos M, Anezinis P, Theodoropoulos PA, Castanas E and Stathopoulos EN. Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections. BMC Cancer. 2005; 148
7. Stathopoulos EN, Dambaki C, Kampa M, Theodoropoulos PA, Anezinis P, Delakas D, Delides GS and Castanas E. Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells. BMC Clin. Pathol. 2003; 1
8. Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN, Stournaras C and Castanas E. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 2002; 11: 1429-1431
9. Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Foller M, Gravanis A, Alevizopoulos K, Lang F and Stournaras C. Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Mol. Cancer. 2008; 88-4598-7-88
10. Lyng FM, Jones GR and Rommerts FF. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations. Biol. Reprod. 2000; 3: 736-747
11. Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A and Castanas E. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol. Cancer. Ther. 2006; 5: 1342-1351
12. Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, Gravanis A and Castanas E. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 2005; 2: 893-903
13. Lang F, Alevizopoulos K and Stournaras C. Targeting membrane androgen receptors in tumors. Expert Opin. Ther. Targets. 2013; 8: 951-963
14. Steinsapir J, Socci R and Reinach P. Effects of androgen on intracellular calcium of LNCaP cells. Biochem. Biophys. Res. Commun. 1991; 1: 90-96
15. Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, Velicelebi G and Stauderman KA. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 2005; 3: 435-445
16. Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE, Jr and Meyer T. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 2005; 13: 1235-1241
17. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R and Kinet JP. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science. 2006; 5777: 1220-1223
18. Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, Roos J, Stauderman KA and Cahalan MD. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc. Natl. Acad. Sci. U.S.A. 2006; 24: 9357-9362
19. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M and Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006; 7090: 179-185
20. Lewis RS. Store-operated calcium channels: new perspectives on mechanism and function. Cold Spring Harb Perspect. Biol. 2011; 12: 10.1101/cshperspect.a003970
21. Wu MM, Buchanan J, Luik RM and Lewis RS. Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J. Cell Biol. 2006; 6: 803-813
22. Stathopulos PB, Li GY, Plevin MJ, Ames JB and Ikura M. Stored Ca2+ depletion-induced oligomerization of stromal interaction molecule 1 (STIM1) via the EF-SAM region: An initiation mechanism for capacitive Ca2+ entry. J. Biol. Chem. 2006; 47: 35855-35862
23. Xu P, Lu J, Li Z, Yu X, Chen L and Xu T. Aggregation of STIM1 underneath the plasma membrane induces clustering of Orai1. Biochem. Biophys. Res. Commun. 2006; 4: 969-976
24. Smyth JT, DeHaven WI, Bird GS and Putney JW, Jr. Role of the microtubule cytoskeleton in the function of the store-operated Ca2+ channel activator STIM1. J. Cell. Sci. 2007; Pt 21: 3762-3771
25. Hoth M and Niemeyer BA. The Neglected CRAC Proteins: Orai2, Orai3, and STIM2. Curr. Top. Membr. 2013; 237-271
26. Putney JW. The physiological function of store-operated calcium entry. Neurochem. Res. 2011; 7: 1157-1165
27. Vanden Abeele F, Skryma R, Shuba Y, Van Coppenolle F, Slomianny C, Roudbaraki M, Mauroy B, Wuytack F and Prevarskaya N. Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer. Cell. 2002; 2: 169-179
28. Shapovalov G, Skryma R and Prevarskaya N. Calcium Channels and Prostate Cancer. Recent. Pat. Anticancer Drug Discov. 2012;
29. Prevarskaya N, Skryma R and Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol. Med. 2010; 3: 107-121
30. Flourakis M, Lehen'kyi V, Beck B, Raphael M, Vandenberghe M, Abeele FV, Roudbaraki M, Lepage G, Mauroy B, Romanin C, Shuba Y, Skryma R and Prevarskaya N. Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. Cell. Death Dis. 2010; e75
31. Wasilenko WJ, Cooper J, Palad AJ, Somers KD, Blackmore PF, Rhim JS, Wright GL, Jr and Schellhammer PF. Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP. Prostate. 1997; 3: 167-173
32. Shiu SY, Pang B, Tam CW and Yao KM. Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Galpha(s) and Galpha(q) proteins. J. Pineal Res. 2010; 3: 301-311
33. Kilch T, Alansary D, Peglow M, Dorr K, Rychkov G, Rieger H, Peinelt C and Niemeyer BA. Mutations of the Ca2+-sensing Stromal Interaction Molecule STIM1 Regulate Ca2+ Influx by Altered Oligomerization of STIM1 and by Destabilization of the Ca2+ Channel Orai1. J. Biol. Chem. 2013; 3: 1653-1664
34. Bogeski I, Kummerow C, Al-Ansary D, Schwarz EC, Koehler R, Kozai D, Takahashi N, Peinelt C, Griesemer D, Bozem M, Mori Y, Hoth M and Niemeyer BA. Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signaling. Sci. Signal. 2010; 115: ra24
35. Ji W, Xu P, Li Z, Lu J, Liu L, Zhan Y, Chen Y, Hille B, Xu T and Chen L. Functional stoichiometry of the unitary calcium-release-activated calcium channel. Proc. Natl. Acad. Sci. U.S.A. 2008; 36: 13668-13673
36. Penna A, Demuro A, Yeromin AV, Zhang SL, Safrina O, Parker I and Cahalan MD. The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers. Nature. 2008; 7218: 116-120
37. Demuro A, Penna A, Safrina O, Yeromin AV, Amcheslavsky A, Cahalan MD and Parker I. Subunit stoichiometry of human Orai1 and Orai3 channels in closed and open states. Proc. Natl. Acad. Sci. U.S.A. 2011; 43: 17832-17837
38. Madl J, Weghuber J, Fritsch R, Derler I, Fahrner M, Frischauf I, Lackner B, Romanin C and Schutz GJ. Resting state Orai1 diffuses as homotetramer in the plasma membrane of live mammalian cells. J. Biol. Chem. 2010; 52: 41135-41142
39. Maruyama Y, Ogura T, Mio K, Kato K, Kaneko T, Kiyonaka S, Mori Y and Sato C. Tetrameric Orai1 is a teardrop-shaped molecule with a long, tapered cytoplasmic domain. J. Biol. Chem. 2009; 20: 13676-13685
40. Thompson JL and Shuttleworth TJ. How Many Orai's Does It Take to Make a CRAC Channel? Sci. Rep. 2013; 1961
41. Hou X, Pedi L, Diver MM and Long SB. Crystal structure of the calcium release-activated calcium channel Orai. Science. 2012; 6112: 1308-1313
42. SoboloffJ, Spassova MA, Hewavitharana T, He LP, Xu W, Johnstone LS, Dziadek MA and Gill DL. STIM2 is an inhibitor of STIM1-mediated store-operated Ca2+ Entry. Curr. Biol. 2006; 14: 1465-1470
43. Prakriya M and Lewis RS. Potentiation and inhibition of Ca(2+) release-activated Ca(2+) channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors. J. Physiol. 2001; Pt 1: 3-19
44. Peinelt C, Lis A, Beck A, Fleig A and Penner R. 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. J. Physiol. 2008; 13: 3061-3073
45. Lis A, Peinelt C, Beck A, Parvez S, Monteilh-Zoller M, Fleig A and Penner R. CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr. Biol. 2007; 9: 794-800
46. Zhang SL, Kozak JA, Jiang W, Yeromin AV, Chen J, Yu Y, Penna A, Shen W, Chi V and Cahalan MD. Store-dependent and -independent modes regulating Ca2+ release-activated Ca2+ channel activity of human Orai1 and Orai3. J. Biol. Chem. 2008; 25: 17662-17671
47. DeHaven WI, Smyth JT, Boyles RR and Putney JW, Jr. Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J. Biol. Chem. 2007; 24: 17548-17556
48. Schindl R, Frischauf I, Bergsmann J, Muik M, Derler I, Lackner B, Groschner K and Romanin C. Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. Proc. Natl. Acad. Sci. U.S.A. 2009; 46: 19623-19628
49. Vanden Abeele F, Shuba Y, Roudbaraki M, Lemonnier L, Vanoverberghe K, Mariot P, Skryma R, Prevarskaya N. Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. Cell Calcium. 2003; 33: 357-73.
50. Prevarskaya N, Skryma R and Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer. 2011; 8: 609-618
51. Prevarskaya N, Skryma R and Shuba Y. Targeting Ca(2)(+) transport in cancer: close reality or long perspective? Expert Opin. Ther. Targets. 2013; 3: 225-241
52. Monteith GR, McAndrew D, Faddy HM and Roberts-Thomson SJ. Calcium and cancer: targeting Ca2+ transport. Nat. Rev. Cancer. 2007; 7: 519-530
53. Hoth M and Penner R. Calcium release-activated calcium current in rat mast cells. J. Physiol. 1993; 359-386
54. Kerschbaum HH and Cahalan MD. Monovalent permeability, rectification, and ionic block of store-operated calcium channels in Jurkat T lymphocytes. J. Gen. Physiol. 1998; 4: 521-537
55. Bakowski D and Parekh AB. Monovalent cation permeability and Ca(2+) block of the store-operated Ca(2+) current I(CRAC)in rat basophilic leukemia cells. Pflugers Arch. 2002; 5-6: 892-902
56. Faouzi M, Hague F, Potier M, Ahidouch A, Sevestre H and Ouadid-Ahidouch H. Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J. Cell. Physiol. 2011; 2: 542-551
57. Faouzi M, Kischel P, Hague F, Ahidouch A, Benzerdjeb N, Sevestre H, Penner R and Ouadid-Ahidouch H. ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. Biochim. Biophys. Acta. 2013; 3: 752-760
58. Motiani RK, Zhang X, Harmon KE, Keller RS, Matrougui K, Bennett JA and Trebak M. Orai3 is an estrogen receptor alpha-regulated Ca2+ channel that promotes tumorigenesis. FASEB J. 2013; 1: 63-75
59. Motiani RK, Abdullaev IF and Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J. Biol. Chem. 2010; 25: 19173-19183
60. Sun YH, Gao X, Tang YJ, Xu CL and Wang LH. Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J. Androl. 2006; 5: 671-678
61. Lieberherr M and Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J. Biol. Chem. 1994; 10: 7217-7223
62. ElBaradie K, Wang Y, Boyan BD and Schwartz Z. Rapid membrane responses to dihydrotestosterone are sex dependent in growth plate chondrocytes. J. Steroid Biochem. Mol. Biol. 2012; 1-2: 15-23
63. Wunderlich F, Benten WP, Lieberherr M, Guo Z, Stamm O, Wrehlke C, Sekeris CE and Mossmann H. Testosterone signaling in T cells and macrophages. Steroids. 2002; 6: 535-538
64. Hoth M and Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature. 1992; 6358: 353-356
65. Clinical Trials database search results: http://clinicaltrials.gov/ct2/show/NCT01056029?term=G-202&rank=2.
66. Denmeade SR, Mhaka AM, Rosen DM, Brennen WN, Dalrymple S, Dach I, Olesen C, Gurel B, Demarzo AM, Wilding G, Carducci MA, Dionne CA, Moller JV, Nissen P, Christensen SB and Isaacs JT. Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Sci. Transl. Med. 2012; 140: 140ra86
67. Gmyrek GA, Walburg M, Webb CP, Yu HM, You X, Vaughan ED, Vande Woude GF and Knudsen BS. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am. J. Pathol. 2001; 2: 579-590
68. Grynkiewicz G, Poenie M and Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985; 6: 3440-3450
69. Mantei A, Rutz S, Janke M, KirchhoffD, Jung U, Patzel V, Vogel U, Rudel T, Andreou I, Weber M and Scheffold A. siRNA stabilization prolongs gene knockdown in primary T lymphocytes. Eur. J. Immunol. 2008; 9: 2616-2625